Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0XU8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,182
Award facts
- Contract value 100% obligated
- $26,182.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,182.45 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of OPDIVO 240 mg/24 ml vials. The contract is a firm fixed price delivery order with an ultimate completion date of December 29, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This prime indefinite delivery vehicle supports customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for OPDIVO, an oncology medication, exemplifies the company's role in fulfilling critical pharmaceutical needs for federal medical supply chains through the DLA's medical procurement operations.
Quick answers
Who was awarded contract SPE2DR26F0XU8?
SPE2DR26F0XU8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F0XU8 worth?
The government has obligated $26,182 on SPE2DR26F0XU8.
Is contract SPE2DR26F0XU8 an order under another contract?
Yes. SPE2DR26F0XU8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XU8 competed?
The extent of competition for SPE2DR26F0XU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award